HIV-1 Testing Market to Reach USD 4.5 Billion by 2033 at a 7.2% CAGR - SRI

London, UK - October 2026 | Strategic Revenue Insights Inc. - The rising prevalence of HIV infections and growing awareness of early diagnosis and treatment are driving growth in HIV-1 testing. According to Strategic Revenue Insights, the global hiv-1 testing market is projected to reach USD 4.5 billion by 2033, registering a CAGR of 7.2% from 2025 to 2033. The report was prepared by lead analyst Kamrul Hasan. The source report does not disclose detailed methodology, including the number of primary interviews or the specific secondary datasets used.

Key Takeaways

• Market value is projected to reach USD 4.5 billion by 2033, at a CAGR of 7.2% from 2025 to 2033.
• Tests include antibody, antigen/antibody, and nucleic acid tests using blood, oral fluid, or urine samples.
• Demand for home-based testing kits is growing for privacy and convenience, and more sensitive and specific assays are improving accuracy.
• North America holds the largest share, while Asia-Pacific is expected to record the highest growth rate.
• Named market participants include Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers.

Report URL: https://www.strategicrevenueinsights.com/industry/hiv-testing-market

Early Diagnosis Needs Drive HIV-1 Testing Demand

Growth is primarily driven by the increasing prevalence of HIV infections worldwide and rising awareness of early diagnosis and treatment. According to UNAIDS, millions of people are living with HIV and a significant portion remain undiagnosed, which is raising demand for testing.

Government initiatives and funding for awareness and testing programs are playing a crucial role, and public health agencies are increasingly adopting HIV-1 testing as part of routine check-ups. Demand for home-based kits is growing, and artificial intelligence and machine learning are expected to reshape diagnostic tools.

Market Segmentation

By Test Type: Antibody Tests, Antigen/Antibody Tests, and Nucleic Acid Tests (NAT).

By Sample Type: Blood, Oral Fluid, and Urine.

By End User: Hospitals, Diagnostic Laboratories, Home Care Settings, and Public Health Agencies.

By Technology: ELISA, Rapid Tests, Western Blot, and PCR. The source does not identify a largest segment.

Regional Outlook

The report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America currently holds the largest market share, attributed to high HIV prevalence and advanced healthcare infrastructure, while Asia-Pacific is anticipated to exhibit the highest growth rate, fueled by rising healthcare expenditure and awareness campaigns. The source provides no further region-specific market values or growth rates.

Competitive Landscape

The report names Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, Hologic, Inc., Thermo Fisher Scientific, Danaher Corporation, OraSure Technologies, Chembio Diagnostics, bioMérieux SA, Qiagen N.V., and Alere Inc. as market participants.

Market Restraints

Stigma and discrimination associated with HIV testing can deter people from seeking testing, particularly where cultural and social norms discourage open discussion.

Related Reports

https://www.strategicrevenueinsights.com/industry/hearing-loss-treatment-device-market

https://www.strategicrevenueinsights.com/industry/absorbable-bone-nail-market

https://www.strategicrevenueinsights.com/industry/epileptic-seizure-monitoring-system-market

https://www.strategicrevenueinsights.com/industry/transcranial-stimulator-market

https://www.strategicrevenueinsights.com/industry/dental-devices-and-consumable-market

https://www.strategicrevenueinsights.com/industry/orthopedics-plates-and-screws-market

https://www.strategicrevenueinsights.com/industry/blood-purification-device-market

https://www.strategicrevenueinsights.com/industry/sheath-introducer-market

https://www.strategicrevenueinsights.com/industry/icu-patient-monitor-market

https://www.strategicrevenueinsights.com/industry/kidney-machines-market

Frequently Asked Questions

What will be the market size by 2033?

The market is projected to reach USD 4.5 billion by 2033.

What is the expected CAGR of the hiv-1 testing market?

The market is projected to expand at a CAGR of 7.2% from 2025 to 2033.

Which segment is largest in the hiv-1 testing market?

The source does not identify a largest segment.

Which region leads the hiv-1 testing market?

North America currently holds the largest market share, attributed to high HIV prevalence and advanced healthcare infrastructure, while Asia-Pacific is anticipated to exhibit the highest growth rate, fueled by rising healthcare expenditure and awareness campaigns.

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., part of SRI Consulting Group Ltd, is a London-headquartered market intelligence firm that helps organizations across industries and geographies make evidence-based revenue and strategy decisions. The firm produces syndicated research reports and customized consulting engagements built on rigorous market sizing, forecasting, and competitive benchmarking, drawing on a globally connected team of analysts and consultants.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44-787-740-3352

Address: Suite 10, Capital House, 61 Amhurst Road, London, E8 1LL, United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

https://www.strategicrevenueinsights.com/press-releases